ICF helps FDA accelerate the drug labeling review process with AWS machine learning
Within the Food and Drug Administration’s Center for Drug Evaluation and Research, the Division of Medication Error Prevention and Analysis (DMEPA) plays a critical role. DMEPA reviews premarket and postmarket drug labeling to minimize the risk of medication errors. In partnership with DMEPA, Amazon Web Services (AWS) Partner ICF is developing a machine learning (ML) prototype known as the Computerized Labeling Assessment Tool (CLAT). The prototype employs innovative applications of optical character recognition (OCR) technology and the novel use of computer vision techniques that will alleviate bottlenecks in and enhance the efficiency of the drug labeling review process.